 Jeffrey Kavanaugh
Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus aureus | 13 | 2024 | 450 | 2.170 |
Why?
| | Quorum Sensing | 12 | 2019 | 77 | 1.840 |
Why?
| | Staphylococcal Infections | 11 | 2022 | 400 | 1.580 |
Why?
| | Biofilms | 9 | 2022 | 260 | 1.460 |
Why?
| | Bacterial Proteins | 14 | 2020 | 879 | 1.360 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 11 | 2024 | 234 | 1.130 |
Why?
| | Lipoproteins | 3 | 2024 | 168 | 0.950 |
Why?
| | Hemoglobins | 7 | 2005 | 353 | 0.790 |
Why?
| | Neutrophils | 3 | 2024 | 1238 | 0.740 |
Why?
| | Cathepsin G | 1 | 2021 | 6 | 0.720 |
Why?
| | Phagocytosis | 1 | 2021 | 380 | 0.610 |
Why?
| | Peptides, Cyclic | 6 | 2019 | 259 | 0.530 |
Why?
| | Hemoglobin A | 6 | 1999 | 21 | 0.510 |
Why?
| | Homoserine | 2 | 2013 | 6 | 0.480 |
Why?
| | Hemoglobins, Abnormal | 4 | 2005 | 11 | 0.460 |
Why?
| | Yersinia pestis | 2 | 2013 | 45 | 0.460 |
Why?
| | Lactones | 2 | 2013 | 56 | 0.460 |
Why?
| | Environment | 1 | 2016 | 358 | 0.430 |
Why?
| | Staphylococcal Skin Infections | 3 | 2020 | 35 | 0.400 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1502 | 0.370 |
Why?
| | Gene Expression Regulation, Bacterial | 5 | 2016 | 328 | 0.330 |
Why?
| | Protein Subunits | 4 | 2005 | 239 | 0.320 |
Why?
| | Virulence | 6 | 2022 | 267 | 0.310 |
Why?
| | Mass Spectrometry | 4 | 2019 | 739 | 0.300 |
Why?
| | Anti-Bacterial Agents | 7 | 2022 | 1809 | 0.280 |
Why?
| | Carrier Proteins | 1 | 2011 | 771 | 0.270 |
Why?
| | Protein Conformation | 6 | 2004 | 934 | 0.260 |
Why?
| | Tyrosine | 2 | 2005 | 222 | 0.260 |
Why?
| | Globins | 2 | 2005 | 22 | 0.260 |
Why?
| | Serine Endopeptidases | 1 | 2007 | 123 | 0.260 |
Why?
| | Protein Structure, Tertiary | 4 | 2011 | 861 | 0.260 |
Why?
| | Models, Molecular | 11 | 2016 | 1570 | 0.250 |
Why?
| | Crystallography, X-Ray | 8 | 2005 | 476 | 0.230 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2024 | 30 | 0.220 |
Why?
| | Cell Membrane | 3 | 2021 | 738 | 0.210 |
Why?
| | Mutation | 8 | 2021 | 3958 | 0.210 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 283 | 0.210 |
Why?
| | Amino Acid Substitution | 2 | 2001 | 307 | 0.200 |
Why?
| | Staphylococcus epidermidis | 2 | 2020 | 77 | 0.190 |
Why?
| | Micrococcal Nuclease | 2 | 2013 | 26 | 0.190 |
Why?
| | Cephalexin | 1 | 2022 | 12 | 0.190 |
Why?
| | Membrane Proteins | 2 | 2013 | 1164 | 0.190 |
Why?
| | Pneumonia, Bacterial | 1 | 2022 | 116 | 0.180 |
Why?
| | Tryptophan | 2 | 2005 | 183 | 0.180 |
Why?
| | Virulence Factors | 4 | 2019 | 167 | 0.180 |
Why?
| | Coinfection | 1 | 2022 | 137 | 0.180 |
Why?
| | DNA, Bacterial | 2 | 2020 | 337 | 0.180 |
Why?
| | Extracellular Traps | 1 | 2021 | 53 | 0.170 |
Why?
| | Trans-Activators | 4 | 2019 | 398 | 0.170 |
Why?
| | Binding Sites | 4 | 2011 | 1303 | 0.170 |
Why?
| | Protein Structure, Quaternary | 4 | 2005 | 128 | 0.170 |
Why?
| | Cysteine Proteases | 1 | 2020 | 7 | 0.170 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2001 | 375 | 0.170 |
Why?
| | Skin | 3 | 2020 | 752 | 0.160 |
Why?
| | Molecular Sequence Data | 5 | 2011 | 2900 | 0.160 |
Why?
| | Blotting, Southwestern | 1 | 2019 | 2 | 0.160 |
Why?
| | Microbial Sensitivity Tests | 5 | 2022 | 361 | 0.160 |
Why?
| | Static Electricity | 1 | 2019 | 118 | 0.150 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2019 | 78 | 0.150 |
Why?
| | Amino Acid Sequence | 3 | 2011 | 2139 | 0.140 |
Why?
| | Plant Extracts | 3 | 2017 | 202 | 0.140 |
Why?
| | Anacardiaceae | 1 | 2017 | 4 | 0.140 |
Why?
| | Staphylococcus lugdunensis | 1 | 2016 | 2 | 0.130 |
Why?
| | Host-Pathogen Interactions | 2 | 2019 | 364 | 0.130 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 329 | 0.130 |
Why?
| | Cyclohexanones | 1 | 2016 | 9 | 0.130 |
Why?
| | Influenza, Human | 1 | 2022 | 622 | 0.130 |
Why?
| | Signal Transduction | 4 | 2024 | 5079 | 0.120 |
Why?
| | Fagaceae | 1 | 2015 | 2 | 0.120 |
Why?
| | Oleanolic Acid | 1 | 2015 | 9 | 0.120 |
Why?
| | Mice, Inbred BALB C | 4 | 2022 | 1272 | 0.120 |
Why?
| | Oxyhemoglobins | 1 | 1995 | 23 | 0.120 |
Why?
| | Emodin | 1 | 2015 | 3 | 0.120 |
Why?
| | Skin Diseases | 1 | 2017 | 149 | 0.120 |
Why?
| | Humans | 27 | 2024 | 137585 | 0.120 |
Why?
| | Mice | 11 | 2022 | 17787 | 0.120 |
Why?
| | Microbiota | 2 | 2020 | 762 | 0.110 |
Why?
| | Antibodies, Monoclonal | 1 | 2022 | 1430 | 0.110 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2016 | 560 | 0.110 |
Why?
| | Penicillium | 1 | 2014 | 6 | 0.110 |
Why?
| | Anthraquinones | 1 | 2014 | 11 | 0.110 |
Why?
| | Rabbits | 4 | 2019 | 794 | 0.110 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 180 | 0.110 |
Why?
| | Hydrogen Bonding | 3 | 2005 | 163 | 0.100 |
Why?
| | Arginine | 1 | 1995 | 271 | 0.100 |
Why?
| | Oxygen | 4 | 2005 | 931 | 0.100 |
Why?
| | Models, Genetic | 1 | 2016 | 600 | 0.100 |
Why?
| | Carbon Monoxide | 2 | 2005 | 81 | 0.100 |
Why?
| | Immunity, Innate | 1 | 2019 | 828 | 0.100 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2013 | 597 | 0.100 |
Why?
| | Hydrastis | 1 | 2012 | 3 | 0.100 |
Why?
| | Berberine | 1 | 2012 | 6 | 0.100 |
Why?
| | Protein Binding | 2 | 2011 | 2224 | 0.100 |
Why?
| | Protein Structure, Secondary | 1 | 1993 | 374 | 0.090 |
Why?
| | Interleukin-8 | 2 | 2024 | 268 | 0.090 |
Why?
| | Repressor Proteins | 1 | 2015 | 427 | 0.090 |
Why?
| | Cells, Cultured | 4 | 2021 | 4193 | 0.090 |
Why?
| | Chlorides | 1 | 1992 | 136 | 0.090 |
Why?
| | Conserved Sequence | 1 | 2011 | 239 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2011 | 343 | 0.090 |
Why?
| | Animals | 12 | 2022 | 36940 | 0.090 |
Why?
| | Kinetics | 3 | 2005 | 1670 | 0.090 |
Why?
| | Protein Kinases | 1 | 2013 | 319 | 0.090 |
Why?
| | Staphylococcus | 1 | 2010 | 76 | 0.080 |
Why?
| | Ethanol | 1 | 2015 | 608 | 0.080 |
Why?
| | Crystallization | 4 | 2004 | 143 | 0.080 |
Why?
| | X-Ray Diffraction | 4 | 1993 | 104 | 0.080 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1092 | 0.080 |
Why?
| | Genes, Reporter | 1 | 2009 | 269 | 0.070 |
Why?
| | Cathelicidins | 2 | 2020 | 41 | 0.070 |
Why?
| | Recombinant Proteins | 3 | 2015 | 1353 | 0.070 |
Why?
| | Luminescent Proteins | 1 | 2009 | 179 | 0.070 |
Why?
| | Alcoholism | 1 | 2015 | 807 | 0.070 |
Why?
| | Toll-Like Receptor 2 | 2 | 2021 | 115 | 0.070 |
Why?
| | Molecular Structure | 3 | 2014 | 489 | 0.070 |
Why?
| | Antimicrobial Cationic Peptides | 2 | 2020 | 81 | 0.070 |
Why?
| | Metalloproteases | 1 | 2007 | 43 | 0.070 |
Why?
| | beta-Lactamases | 1 | 2007 | 48 | 0.070 |
Why?
| | Biological Assay | 1 | 2007 | 124 | 0.070 |
Why?
| | Keratinocytes | 2 | 2020 | 249 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 5757 | 0.060 |
Why?
| | Substrate Specificity | 1 | 2007 | 372 | 0.060 |
Why?
| | Thermodynamics | 2 | 2001 | 407 | 0.060 |
Why?
| | Hemolysin Proteins | 2 | 2017 | 34 | 0.060 |
Why?
| | Ligands | 2 | 2005 | 664 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 2 | 2016 | 90 | 0.060 |
Why?
| | Mutagenesis, Insertional | 1 | 2005 | 65 | 0.060 |
Why?
| | Allosteric Regulation | 1 | 2005 | 97 | 0.060 |
Why?
| | Spectrum Analysis, Raman | 1 | 2005 | 41 | 0.060 |
Why?
| | Peptides | 1 | 2010 | 985 | 0.060 |
Why?
| | Dimerization | 1 | 2005 | 199 | 0.060 |
Why?
| | Solutions | 1 | 2005 | 168 | 0.060 |
Why?
| | Cross-Linking Reagents | 1 | 2005 | 217 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2007 | 840 | 0.050 |
Why?
| | Inflammation | 1 | 2015 | 2837 | 0.050 |
Why?
| | Cytotoxins | 1 | 2022 | 16 | 0.050 |
Why?
| | Heparitin Sulfate | 1 | 2022 | 50 | 0.050 |
Why?
| | Cephalothin | 1 | 2022 | 6 | 0.050 |
Why?
| | Oxacillin | 1 | 2022 | 6 | 0.050 |
Why?
| | Methicillin | 1 | 2022 | 11 | 0.050 |
Why?
| | Cefadroxil | 1 | 2022 | 10 | 0.050 |
Why?
| | Cefazolin | 1 | 2022 | 21 | 0.050 |
Why?
| | Teichoic Acids | 1 | 2022 | 14 | 0.050 |
Why?
| | Macromolecular Substances | 2 | 1992 | 229 | 0.050 |
Why?
| | Toll-Like Receptor 1 | 1 | 2021 | 12 | 0.050 |
Why?
| | Lipoylation | 1 | 2021 | 17 | 0.050 |
Why?
| | Reactive Oxygen Species | 1 | 2024 | 622 | 0.050 |
Why?
| | Pancreatic Elastase | 1 | 2021 | 58 | 0.050 |
Why?
| | Photolysis | 1 | 2001 | 91 | 0.040 |
Why?
| | Catheter-Related Infections | 1 | 2022 | 92 | 0.040 |
Why?
| | Desmoglein 1 | 1 | 2020 | 2 | 0.040 |
Why?
| | Phosphorylation | 1 | 2024 | 1759 | 0.040 |
Why?
| | Valine | 3 | 1999 | 82 | 0.040 |
Why?
| | Methionine | 3 | 1999 | 160 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2004 | 915 | 0.040 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 184 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2013 | 3284 | 0.030 |
Why?
| | Toxins, Biological | 1 | 2017 | 12 | 0.030 |
Why?
| | Soft Tissue Infections | 1 | 2017 | 37 | 0.030 |
Why?
| | Necrosis | 1 | 2017 | 246 | 0.030 |
Why?
| | Bacteria | 1 | 2022 | 858 | 0.030 |
Why?
| | Drug Discovery | 1 | 2016 | 142 | 0.030 |
Why?
| | Hypersensitivity, Delayed | 1 | 2015 | 28 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2015 | 60 | 0.030 |
Why?
| | Interleukin-23 | 1 | 2015 | 19 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 1995 | 171 | 0.030 |
Why?
| | Bacterial Toxins | 1 | 2015 | 106 | 0.030 |
Why?
| | Bacterial Load | 1 | 2015 | 68 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 107 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2016 | 390 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 101 | 0.030 |
Why?
| | Escherichia coli | 1 | 1999 | 815 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2017 | 4295 | 0.030 |
Why?
| | Sodium Chloride | 1 | 1995 | 142 | 0.030 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 186 | 0.030 |
Why?
| | Interleukin-17 | 1 | 2015 | 119 | 0.030 |
Why?
| | Peptide Hydrolases | 1 | 2015 | 111 | 0.030 |
Why?
| | Plant Leaves | 1 | 2015 | 147 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 1995 | 570 | 0.030 |
Why?
| | Alleles | 1 | 2017 | 891 | 0.030 |
Why?
| | Myeloid Cells | 1 | 2015 | 148 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2189 | 0.030 |
Why?
| | Microarray Analysis | 1 | 2013 | 117 | 0.030 |
Why?
| | Leukocytes | 1 | 2015 | 311 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2015 | 202 | 0.030 |
Why?
| | Genes, Bacterial | 1 | 2013 | 164 | 0.030 |
Why?
| | Regulon | 1 | 2013 | 36 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2015 | 347 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2015 | 372 | 0.020 |
Why?
| | Plants, Medicinal | 1 | 2012 | 22 | 0.020 |
Why?
| | Microbial Viability | 1 | 2013 | 91 | 0.020 |
Why?
| | Chemistry, Physical | 1 | 1992 | 37 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 417 | 0.020 |
Why?
| | Anions | 1 | 1992 | 31 | 0.020 |
Why?
| | Chemical Phenomena | 1 | 1992 | 83 | 0.020 |
Why?
| | Peritonitis | 1 | 2013 | 84 | 0.020 |
Why?
| | Bacteremia | 1 | 2015 | 214 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2828 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2015 | 491 | 0.020 |
Why?
| | Gene Deletion | 1 | 2013 | 391 | 0.020 |
Why?
| | Alanine | 1 | 1992 | 152 | 0.020 |
Why?
| | Sigma Factor | 1 | 2011 | 40 | 0.020 |
Why?
| | Hemolysis | 1 | 2013 | 206 | 0.020 |
Why?
| | RNA Polymerase III | 1 | 2010 | 28 | 0.020 |
Why?
| | Male | 4 | 2022 | 67762 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1250 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2013 | 443 | 0.020 |
Why?
| | Erythrocytes | 1 | 2015 | 700 | 0.020 |
Why?
| | Cell Line | 1 | 2015 | 2847 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4060 | 0.020 |
Why?
| | Weight Loss | 1 | 2015 | 787 | 0.020 |
Why?
| | Plasmids | 1 | 2009 | 363 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 402 | 0.020 |
Why?
| | Cytokines | 1 | 2015 | 2085 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2013 | 1317 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1774 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2009 | 1178 | 0.010 |
Why?
| | Transcription Factors | 1 | 2013 | 1719 | 0.010 |
Why?
| | Anaerobiosis | 1 | 2004 | 64 | 0.010 |
Why?
| | Histidine | 1 | 2004 | 64 | 0.010 |
Why?
| | Female | 3 | 2019 | 73304 | 0.010 |
Why?
| | Heme | 1 | 2004 | 78 | 0.010 |
Why?
| | Cysteine | 1 | 2004 | 204 | 0.010 |
Why?
| | Child | 1 | 2022 | 21935 | 0.010 |
Why?
| | Sulfhydryl Compounds | 1 | 2004 | 189 | 0.010 |
Why?
| | Iron | 1 | 2004 | 313 | 0.010 |
Why?
| | Hemoglobin M | 1 | 1999 | 2 | 0.010 |
Why?
| | Chemical Fractionation | 1 | 1999 | 26 | 0.010 |
Why?
| | Peptide Fragments | 1 | 1999 | 706 | 0.010 |
Why?
| | Computer Simulation | 1 | 1997 | 978 | 0.010 |
Why?
| | Glutamates | 1 | 1992 | 59 | 0.010 |
Why?
| | Acetylation | 1 | 1992 | 248 | 0.010 |
Why?
| | Aged | 1 | 1992 | 23961 | 0.000 |
Why?
|
|
Kavanaugh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|